In line with our results and their clinical relevance, a recent report on AZD3241 treatment in PD patients showed reduced levels of [11C]PBR28 binding to dopamine transporter and translocator protein in PET imaging indicating suppressed microglia activity (Jucaite et al., 2014). This evidence concerns the gene SLC6A3 and Parkinson disease.